Featured Research

from universities, journals, and other organizations

Coronary Artery Bypass Graft Surgery Promising In 90-Year-Olds

Date:
February 7, 2008
Source:
Yale University
Summary:
Coronary artery bypass graft (CABG) surgery is becoming increasingly common, and appears to be a viable treatment, among individuals in their 90s, according to a study published in the American Journal of Cardiology. CABG surgery creates new pathways around narrowed and blocked arteries, allowing sufficient delivery of blood, oxygen, and nutrients to the heart. Researchers studied the outcomes of the surgery on 4,224 nonagenarian Medicare patients who underwent the procedure from 1993 through 1999.

Coronary artery bypass graft (CABG) surgery is becoming increasingly common, and appears to be a viable treatment, among individuals in their 90s, according to a study published in the American Journal of Cardiology.

CABG surgery creates new pathways around narrowed and blocked arteries, allowing sufficient delivery of blood, oxygen, and nutrients to the heart. Researchers studied the outcomes of the surgery on 4,224 nonagenarian Medicare patients who underwent the procedure from 1993 through 1999.

“Our results indicate that nonagenarians who are currently selected for CABG procedures can achieve years of life consistent with their elderly peers,” said Judith Lichtman, associate professor of epidemiology at Yale School of Public Health and lead author of the study.

CABG surgeries rose from 325 in 1993 to 883 in 1999. The researchers did follow-up studies five years after the procedures and found that women—who made up half of the patients—had better post-surgical survival rates than men. The women, however, were more likely to be discharged to a nursing home after the surgery.

The authors said additional research is needed to assist patients and physicians in determining the appropriateness of these procedures for this elderly population.

Co-authors include Norinna Allen, Yun Wang, Roger Kapoor, Martha Radford, M.D., and Harlan Krumholz, M.D.

American Journal of Cardiology: December 2007


Story Source:

The above story is based on materials provided by Yale University. Note: Materials may be edited for content and length.


Cite This Page:

Yale University. "Coronary Artery Bypass Graft Surgery Promising In 90-Year-Olds." ScienceDaily. ScienceDaily, 7 February 2008. <www.sciencedaily.com/releases/2008/02/080202124039.htm>.
Yale University. (2008, February 7). Coronary Artery Bypass Graft Surgery Promising In 90-Year-Olds. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2008/02/080202124039.htm
Yale University. "Coronary Artery Bypass Graft Surgery Promising In 90-Year-Olds." ScienceDaily. www.sciencedaily.com/releases/2008/02/080202124039.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins